A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404).
- Resource Type
- Article
- Source
- Esophagus; Oct2022, Vol. 19 Issue 4, p711-716, 6p
- Subject
- Language
- ISSN
- 16129059